Photodynamic Therapy Market: Introduction

Photodynamic therapy (PDT) is a treatment that involves special drugs termed as photosensitizing agents. Photosensitizing agents are used along with light to destroy the cancer cells present inside a patient’s body. A light-activated drug is often referred to as a photosensitizer. The drugs injected or induced into the body can only be activated with the help of a special type of light. Photodynamic therapy (PDT) is also known as phototherapy, photochemotherapy, or photoradiation therapy. The part of the body to be treated determines the route of administration of photosensitizers i.e. whether they should be injected through the blood stream or be applied onto the skin surface. Over a period of time, the drug gets absorbed by the cancerous cells. The light catalyzes the reaction. The light of a particular wavelength is allowed to fall onto the affected area, which causes the drug to react with oxygen in the cells. It forms a chemical compound that destroys the cancerous cells. Photodynamic therapy has also been used to annihilate the blood supply from the blood vessels, which nourishes the cancerous cells. The drug administered and the light allowed to fall onto the affected area are concerned with a particular time span which can be termed as drug-to-light interval. The time may vary from a couple of hours to a couple of days and further, to weeks, completely depending on the drug used for the treatment.

Need an Overview of the Report on Photodynamic Therapy Market? Ask for the Brochure here

Photodynamic Therapy Market: Competitive Landscape

Sun Pharmaceutical Industries Ltd

Sun Pharma is the world’s fifth-largest pharmaceutical company producing specialty generics. The company is expanding its global footprint as a highly trusted pharmaceutical company among consumers and healthcare professionals in over 100 countries. It runs multiple manufacturing facilities and R&D centers across the world. The company has operations spanning across sectors such as specialty products, branded generics, complex & pure generics, over-the-counter (OTC) products, anti-retrovirals (ARVs), and active pharmaceutical ingredients (APIs). It also manufactures intermediates for specialty APIs, offering a complete range of dosage forms including tablets, capsules, injectables, ointments, creams, and liquids. The company has more than 32,000 employees across the globe. As an innovation-driven enterprise, the company has high R&D capabilities with investments of over 8.6% of its annual revenues.

Galderma S.A.

Galderma S.A. is a pharmaceutical company engaged in research, development, and marketing of dermatological treatments. It is a subsidiary of Nestlé. Galderma was established in 1981 as a joint venture between Nestlé and L'Oréal. Galderma provides a range of products for use in the treatment of acne, rosacea, psoriasis and other steroid-responsive dermatoses (SRDs), onychomycosis (fungal nail infection), pigmentary disorders, skin cancer, and skin senescence. Galderma has presence in more than 70 countries across the globe.

BIOFRONTERA AG

Biofrontera is a biopharmaceutical company specialized in the development and commercialization of dermatological medications and medical cosmetics. Biofrontera is fully focused on photodynamic therapy and is an expert in this market.

Stuck in a Neck-to-Neck Competition with Other Brands? Request a Custom Report on “Photodynamic Therapy Market” here

Photodynamic Therapy Market: Dynamics

Limited competition in global photodynamic therapy market

Limited competition in the global photodynamic therapy market prompts key manufacturers to expand their business by introducing innovative and upgraded phototherapy solutions in the market. This factor is driving the global photodynamic therapy market. Photodynamic therapy is one of the most successful treatment options for actinic keratosis, skin diseases, and basal cell carcinomas.

 Global Photodynamic Therapy Market: Segmentation

Based on photosensitizer drug, the global photodynamic therapy market can be segmented into:

  • Porphyrins
  • Porphyrin Precursors
  • Phthalocyanines
  • Porphycenes
  • Chlorines
  • Pheophorbides
  • Others

In terms of light device, the global photodynamic therapy market can be bifurcated into:

  • Disposable Fiber Optic Light Delivery Devices
  • Diode Lasers

Based on application, the global photodynamic therapy market can be segregated into:

  • Basal Cell Carcinoma
  • Actinic Keratosis
  • Others

Based on end-user, the global photodynamic therapy market is divided into:

  • Hospitals
  • Cancer Centers
  • Others

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

The study is a source of reliable data on:

  • Market segments and sub-segments
  • Market trends and dynamics
  • Supply and demand
  • Market size
  • Current trends/opportunities/challenges
  • Competitive landscape
  • Technological breakthroughs
  • Value chain and stakeholder analysis

The regional analysis covers:

  • North America (U.S. and Canada)
  • Latin America (Mexico, Brazil, Peru, Chile, and others)
  • Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
  • Eastern Europe (Poland and Russia)
  • Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
  • Middle East and Africa (GCC, Southern Africa, and North Africa)

The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.

A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.

Highlights of the report:

  • A complete backdrop analysis, which includes an assessment of the parent market
  • Important changes in market dynamics
  • Market segmentation up to the second or third level
  • Historical, current, and projected size of the market from the standpoint of both value and volume
  • Reporting and evaluation of recent industry developments
  • Market shares and strategies of key players
  • Emerging niche segments and regional markets
  • An objective assessment of the trajectory of the market
  • Recommendations to companies for strengthening their foothold in the market   

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.